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Alzheimer's disease (AD) is a protein misfolding disease. Early hypothesis of AD pathology posits that 39–43 AA long misfolded amyloid beta (Aβ)
peptide forms a fibrillar structure and induces pathophysiological response by destabilizing cellular ionic homeostasis. Loss of cell ionic homeostasis is
believed to be either indirectly due to amyloid beta-induced oxidative stress or directly by its interaction with the cell membrane and/or activating pathways
for ion exchange. Significantly though, no Aβ specific cell membrane receptors are known and oxidative stress mediated pathology is only partial and
indirect. Most importantly, recent studies strongly indicate that amyloid fibrils may not by themselves cause AD pathology. Subsequently, a competing
hypothesis has been proposed wherein amyloid derived diffusible ligands (ADDLs) that are large Aβ oligomers (∼N60 kDa), mediate AD pathology. No
structural details, however, of these large globular units exist nor is there any known suitable mechanism by which they would induce AD pathology.
Experimental data indicate that they alter cell viability by non-specifically changing the plasma membrane stability and increasing the overall ionic
leakiness. The relevance of this non-specific mechanism for AD-specific pathology seems limited. Here, we provide a viable new paradigm: AD pathology
mediated by amyloid ion channels made of small Aβ oligomers (trimers to octamers). This review is focused to 3D structural analysis of the Aβ channel.
The presence of amyloid channels is consistent with electrophysiological and cell biology studies summarized in companion reviews in this special issue.
They show ion channel-like activity and channel-mediated cell toxicity. Amyloid ion channels with defined gating and pharmacological agents would
provide a tangible target for designing therapeutics for AD pathology.
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Alzheimer's disease (AD) belongs to a class of degenerative
diseases commonly referred to as a protein misfolding disease that
includes many other neurodegenerative diseases (such as Hun-
tington's, Parkinson's, familial British and Danish Dementia's) as
well as certain systemic diseases (such as type II Diabetes and
amyloidosis). A common feature of these protein misfolding
diseases is that an abnormal folding of peptides favors conversion
of these proteins from a native, often soluble form, to a nonnative,
often insoluble structure [1–4]. Consistent with this scenario, the
main pathological hallmark in AD brain is the progressive
deposition of amyloid plaques: the bundles of amorphous Aβ
fibers. One of the original dogmas regarding the proteinmisfolding
(or conformational) diseases is that these fibrillar Aβ (thatmake the
amyloid plaques) induce pathophysiological response due to
activation of a signaling pathway that subsequently destabilize
cellular ionic homeostasis. On the other hand, recent studies lead usFig. 1. Ion channel hypothesis for AD pathology. (A) Aβ, a 39–43 AA long peptid
precursor protein (APP). (B) Aβ undergoes multi-step oligomerization, ranging from
ADDLs) to protofibrils to fibrils and plaques. In normal physiological conditions, m
mechanisms for neurotoxic activity of Aβ have been proposed, such as activation o
oxidative stress due to protein aggregates, or recruitment of factors by intracellular
disrupting cell membrane viability, like a hammer hitting a leaf). Small oligomers (m
denominator for AD toxicity is mainly the gain of intracellular calcium, the severity o
capability. See [4,14,26,47,48,50].to believe that these amyloid plaques might not be the cause of the
disease [5–13] — amyloid toxicity could be reproduced without
the presence of any amyloid fibers but by only small or large
oligomeric amyloids. Also, in amyloid animal models, there are
AD-like symptoms without any significant level of amyloid
plaques.
Large oligomeric amyloids have attracted considerable attention
recently and a new dogma has been proposed wherein large
amyloid oligomers that are primarily the Amyloid derived
diffusible ligands (ADDLs) are responsible for amyloid-induced
toxicity [9]. These large amyloid oligomers have been isolated
using antibodies made against ADDLs; and these antibodies by
themselves have been effective in prevention of amyloid cell
toxicity. There are certain caveats with this line of work. First of all,
as their name implies, they are the diffusible “ligands” and yet there
is no specific “receptor”, let alone the cell membrane receptors. For
these ADDLs no specific cell receptors have been identified.
Second, it is unclear how these large, most likely unstructured,e is cleaved from the single transmembrane spanning precursor, called amyloid
the formation of small oligomers to large oligomers (commonly referred to as the
ost of the secreted amyloids remain monomers or small oligomers. (C) Several
f a signaling pathway by extracellular aggregates (fibrils, plagues), induction of
aggregates. Large oligomers (or the ADDLs) may be toxic by non-selectively
ono- and dimers) fold into the membrane forming ion channels. (D) A common
f toxicity depends upon the level of calcium loading as well as the cell's defense
Fig. 2. Morphological changes induced in neuronal cells by Aβ (1–42). Cells are
loaded with calcein AM. Images A, C, E and G are taken as control before online
addition of Aβ (1–42). Images B, D, F and H are taken 45 min after addition of
Aβ (1–42). No morphological degeneration is observed for cells not treated with Aβ
(1–42) (panels A and B). Significant degeneration is observed for cells treated with
50 nMAβ (1–42) (panelD), indicatedby arrows. Loss of cell–cell contact andneurite
beading is observed after treatment with 500 nMAβ (1–42) (panel F), and 5 μMAβ
(1–42) leads to loss of neuronal processes and fragmented neurites [11]. Scale bars
10 μm.
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ability. Recent biophysical studies on these ADDLs indicate that
they allow non-specificmovement of ions across lipid bilayers [14]
by thinning the membrane and altering the dielectric properties.
This appears to be something like an amyloid hammer thinning the
plasma membrane by its shear weight when it interacts with the
membrane. Third, it will be extremely difficult to rule out the
presence of small oligomers in the ADDL preparations, in spite oftheir purification using anti-ADDL antibody and filtration of larger
oligomers and fibers. ADDLs are formed from a prolonged
incubation of small oligomeric peptides.
Small oligomeric amyloids (e.g., monomeric to octameric
amyloid beta complex) have also been shown to reproduce amyloid
toxicity that were previously thought to be due to amyloid fibers
and plaques [3,6,8,11–13]. Our study as well as studies by many
other investigators indicate that Aβ undergo conformational
changes during its interaction with cell membrane such that they
assume specific functional properties consistent with an ion
channel and form specific 3D channel-like structures supporting
the channel activity. These ion channels which normally favor
cationic transport would destabilize the cell ionic homeostasis. This
loss of ionic homeostasis predominantly enhances cellular calcium
concentration that in turn would induce cell toxicity. Significantly,
it is possible that large oligomers (ADDLs) are made of small
oligomers (trimers, tetramers, hexamers, and like) and these small
oligomers have channel-like activity and structural feature, thus
reconciling the two dogmas.
Based on results from abovementioned recent studies and the
discussions to follow in this article, on the possibility that small
amyloid oligomers form ion channels, we present an overall
amyloid channel hypothesis. Fig. 1 summarizes the key feature of
this hypothesis. Briefly, Aβ, a 39- to 43-amino acid long peptide,
when released in the medium after its cleavage from the single
transmembrane spanning precursor called amyloid precursor
protein (APP), undergo multi-step oligomerization, ranging from
the formation of small oligomers to large oligomers (commonly
referred to as the ADDLs) to protofibrils to fibrils and plaques. All
amyloid forms have been reported to alter synaptic information
processing and induce neurotoxicity. A common denominator for
amyloid beta AD toxicity is the gain of intracellular calcium, the
severity of toxicity depends upon the level of calcium loading as
well as the cell's defense capability. How these various amyloid
forms induce pathophysiological responses is the matter of intense
research. Several mechanisms for Aβ neurotoxic activity have
been proposed, such as the activation of a signaling pathway by
extracellular aggregates (fibrils, plagues), induction of oxidative
stress due to protein aggregates, or recruitment of factors by
intracellular aggregates. In some instances, these amyloids,
especially large amyloid complexes and amyloid fibers, might
not interact with cell membrane to affect their toxic effects. But in
most instances, they interact with the cell membrane. Large
oligomers (or the ADDLs) are toxic by non-selectively disrupting
cell membrane viability, perhaps like a hammer hitting a leaf. Small
oligomers (mono- and dimers), on the other hand, allow ion
permeability through newly formed ion channels. The following
description aims to provide key evidence for this amyloid ion
channel paradigm.
2. Globular amyloids induce cellular degeneration in live cells
In normal cellular metabolism, Aβ is continuously released in
pico- to nanomolar concentrations and are present in both the
extracellular and cytoplasmic regions. Globular amyloid beta is
reported to induce known AD pathophysiological features,
namely, a loss of synaptic degeneration and eventual cell death.
Fig. 4. Confocal calcium green fluorescence images of endothelial cells before (A), an
waves are consistent with extracellular calcium uptake and amyloid [6].
Fig. 3. Cell viability assay of neuronal cells treated with Aβ (1–42). Cellular toxicity
induced byAβ (1–42)was blocked by Zn2+ and by removal of extracellular calcium,
but not by tachykinin orNMDAantagonist. Fluorescence images of cells treatedwith
calcein (live cells, left panels) and ethidiumhomodimer 1 (dead cells, right panels) are
shown after Aβ (1–42) treatment. Panels A and B show control cells not treated with
Aβ (1–42), panelsC andD showcells treatedwith 10μMAβ (1–42), panels E andF
showcells afterAβ (1–42) treatment in the absence of extracellular calcium, panelsG
andH show cells after Aβ (1–42) treatment in the presence of 50 μMZnCl2, panels I
and J show cells after Aβ (1–42) treatment in the presence of 20 μM tachykinin
(physalaemin), and K and L show cells after Aβ (1–42) treatment in the presence of
20 μMMK-801, an NMDA receptor antagonist [11].
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cause profound cytoskeletal damage and cell death [6,11,13]. In
these studies, after online addition of very low concentrations of
freshly prepared amyloid beta, cell degeneration began within 15–
20 min, the time too short to form any fibrillar amyloids.
Moreover, Aβ-induced cytoskeletal degeneration and cell death
was dose-dependent (Fig. 2) [6,11,13] and Aβ-induced cell
degeneration and eventual death can be prevented by anti-Aβ
antibody [6,11,13] as well as by many physiological and
pharmacological agents. Prevention of cellular degeneration due
to the presence of antibodies against the amyloids shows that the
toxicity is amyloid specific. Fig. 3 summarizes results from a study
by Lin et al. supporting the channel-mediated toxicity [11].
Significantly, in the presence of physalaemin, a tachykinin, Aβ
(1–42) still induced significant cell degeneration suggesting that
the Aβ (1–42) induced pathophysiological response is not
mediated via a previously proposed tachykinin neuropeptide
pathway, a potential amyloid beta receptor [15]. Also,MK-801, an
NMDA receptor antagonist did not prevent Aβ (1–42)-induced
toxicity. On the other hand, in absence of Ca2+ in the medium, Aβ
(1–42) did not induce cellular degeneration [6,13], and Zinc
provided the cells with a strong protection against the amyloid
toxicity. The final set of controls supports the notion that amyloid-
induced pathophysiological response requires extracellular calci-
um and Zinc is a specific antagonist of amyloid-induced cell
toxicity. It is commonly believed that CA2+ does not modulate
amyloid toxicity from the outside but from the inside after its
cellular uptake.
3. Aβ-mediated calcium uptake
Consistentwith the abovementioned reasoning, Bhatia et al. and
Lin et al. have shown amyloid beta channel-mediated calcium
uptake [6,11]. In these studies, only freshly prepared amyloid beta
(without any large oligomers or fibers) were used. Fig. 4 shows
summary results from one such studies using Calcium Green, a
calcium sensitive dye, and laser confocal microscopy. A transient
and often repetitivewave ofCa2+ was observed in cells shortly after
their treatment with Aβ (1–42) but only when the extracellular
medium contained Ca2+.
These calcium waves were observed for concentrations as
low as 0.22 μM Aβ (1–42) and increased with increasingd after addition of 0.22 μM (B), and 2.2 μM (C) of Aβ (1–42). Observed calcium
Fig. 5. Amyloid beta(1–42) deposited on mica after incubation in PBS for 3 h
(left) and 48 h (right). Even after long incubation time the majority of peptide is
still in globular form, although some fibrils are observed [11].
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and the Ca2+ wave pattern is consistent with the possibility that
Aβ forms Ca2+-permeable channels in the plasma membrane.
The intracellular calcium imaging also showed that Aβ (1–42)
causes rapid cellular damage unlikely to be caused by an oxidative
mechanism but indeed initiated by calciumuptake viaAβ. Such an
increased cellular calcium level can change the local micro-
mechanical properties of cells [16] and induce cytoskeletal
reorganization, one of the earliest detectable changes observed in
neurodegenerative disorders such as AD [17].Fig. 6. Electrophoresis of British amyloid (ABri), Danish Amyloid (ADan), Alph
membrane induced oligomerization. In solution monomers, and sometimes dimers
octamers are observed. The insets show circular dichroism spectra of the amyloidsThe possibility that the Aβ-mediated cellular Ca2+ uptake is
due to amyloid beta forming Ca2+-sensitive ion channels was
reported earlier by Kawahara and his colleagues [18,19]. They
have recordedZinc-sensitiveCa2+ currents fromnewly createdAβ
channels in neuronal membranes. Their results were consistent
with the possibility that the Ca2+ currents were observed after the
interaction of Abeta with the neuronal membrane and forming
Abeta ion channels.
4. Membrane-associated conformational changes
AFM imaging provides the direct evidence that Aβ at a low
(physiological) concentration and in physiologically relevant
buffers remain globular and do not form fibrils for hours to several
days (Fig. 5) [20]. Aggregation properties of monomeric amyloids
depend on the preparation and environmental conditions. Zinc
accelerates oligomerization to larger sized amyloid aggregates, a
process which is reversible by online addition of the Zinc chelator
EDTA. Subsequent studies from various laboratories indicate that
the aggregation behavior also depends on the pH of the solution as
well as the nature of the cations present in the solution [21–24].
Amyloids undergo conformational changes when they
associate with lipidic membrane and membrane-associateda-synuclein, Amylin, Serum Amyloid A, and Amyloid Beta (1–40), showing
(ABri, Amylin, Aβ (1–40)) are observed. In the membrane oligomers up to
in solution.
Fig. 7. Uptake of 45Ca2+ in lipid vesicles reconstituted with Aβ (1–40). Uptake is
blocked partially by anti-Aβ (1–40) antibody, and completely blocked by zinc.
Fig. 8. AFM images of liposomes prepared by bath sonication, reconstituted
with (left) and without (right) Aβ (1–40) [25].
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their non-membranous associations. Biochemical and biophy-
sical studies strongly support the notion that a range of
misfolded proteins when they interact with lipid membrane
make oligomeric complexes [11,25–27]. In an elegant recent
study, Quist et al. reported that globular monomers (and a small
fraction of dimers) of soluble amyloid peptides when inserted in
lipidic bilayer membrane undergo specific oligomerization
regime, i.e., while in solution mostly monomers and sometimes
dimers of these amyloids are observed, in the membrane
oligomers up to octamers are observed (Fig. 6) [26]. The insets
in the figure show circular dichroism spectra of the amyloids in
solution supporting their varying alpha helical to beta sheet or
mixed alpha helical and beta sheet conformations before their
insertion into membrane.
In addition to their membrane-induced oligomerization, some
preformed oligomeric soluble complexes may also retain their
structure after their insertion into a bilayer [11,28]. In addition, the
presence of large oligomeric complexes (such as ADDLs) made up
of small oligomers is not ruled out. These large oligomers, however
altermembrane permeability not through ion channel pathways but
by reducing the height of the dielectric barrier provided by the
bilayer [14]. Globular amyloids have been shown to induce
deleterious effects, by either non-specific membrane leakage
[29,30], or by formation of ion channel like structures
[11,25,26,31]. As described below, atomic Force Microscopy
(AFM) studies have shown the presence of amyloid ion channels in
lipid bilayers [11,25–27]. These and other studies also suggest that
amyloid peptide oligomers can form supra molecular structures
[19,25–27,32–36].
5. Amyloids reconstituted in lipid bilayers exhibit channel
like behavior
A series of studies have reported that small oligomeric amyloids
have channel-like properties and form channel-like structures
[11,25–27,31,33,37]. Lin et al. examined such possibility by using
a permeability assay and compared the results with those obtained
by other groups using electrophysiological channel current
measurements. Results from 45Ca2+ uptake studies in Lin's study(Fig. 7) confirmed such a possibility— the transport of Ca2+ into
lipid vesicles reconstituted with Aβ was observed [25].
The 45Ca2+uptake was partially blocked using antibodies raised
against the N-terminal region of Aβ (1–40), which shows the Aβ
(1–40) specificity of the calcium uptake. Ca2+-uptake was
completely blocked by Zinc; Zinc can competitively bind to
negatively charged phospholipid head groups. Alternately, Arispe
et al. [38] had reported that Zinc blocks Abeta currents by direct
interaction with the Abeta molecule itself, most likely by an
interaction with the Abeta histidine residues located in the entrance
of the amyloid pore [38]. Similar results were obtained in
experiments measuring the Ca2+-uptake in vesicles reconstituted
with Aβ (1–42) [27]. In these vesicles, 45Ca2+-uptakewas strongly
reduced using antibodies against the amyloid peptide, and
completely prohibited by allowing for Zinc or Tris ions in the
medium. However, anti-oxidants did not prevent the calcium
uptake, and thus seem to have no significant influence on the Aβ
channel mediated ionic exchange [27].
AFM imaging of such lipid vesicles shows that vesicles
reconstituted with Aβ have a well-defined vesicular structure and
range in size from200 to 500 nmalongwith only a small fraction of
larger vesicles. Fig. 8 illustrates AFM images of vesicles formed by
reconstituted Aβ (1–40). Force dissection by AFM indicates that
such vesicles are unilamellar [25]. Similar resultswere observed for
liposomes reconstituted for Aβ (1–42) [27].
As discussed previously, a common denominator for amyloid
toxicity is an altered cellular calcium level [39] that could be either
through modulation of existing calcium channels, or through Aβ-
channels. Consistent with the amyloid-channel mediated calcium
uptake, when Aβ is reconstituted in artificial lipid bilayers, cation
selective currents through the reconstituted bilayers are observed
[32,38]. Similarly, Aβ elicits such currents when incubated with
patches excised from hypothalamic GnRH neurons [18].
6. High resolution structure of amyloid channels
In order to justify the abovementioned reasoning for amyloid
channel activity and channel-mediated cell degeneration, it is
important to show that small oligomeric amyloids form ion channel
structures in purified or reconstitutedmembrane as well as in whole
cell plasma membrane. Examining amyloid channel structure in
intact cell membrane is a difficult proposition. For cells with
naturally expressing APP, it will be difficult to distinguish amyloid
Fig. 10. High resolution AFM images of different amyloids reconstituted in lipid
bilayers. The image sizes are 20 nm. Different conformations and subunit arrange-
ments can be observed, consistent with the results from parallel electrophoresis
studies [26].
Fig. 9. AFM images of Aβ (1–40) and Aβ (1–42) reconstituted in bilayers.
Images are amplitude images acquired in tapping mode. Donut shaped features
are observed with sizes ranging from 8 to 15 nm [11,26]. The inset shows a
larger scale membrane patch.
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that matter from any other ion channels present in the cell
membrane. Ideally, one would need cells that do not express APP
and these cells when incubated with globular amyloids retain their
viability and have significant number of amyloid channels. Then,
these channels should also be identified unequivocally, and the
imaging resolution should be high enough to provide the 3D
structural information. The main hurdle for such studies is the lack
of a high resolution imaging technique for whole cells and the
difficulty of proper identification of these channels. Existing high-
resolution techniques, such as electronmicroscopy (EM) andX-ray
diffraction require a highly crystalline patch of similar structures
and extensive sample preparation protocols that are not easily
amenable to amyloid studies. AFM integrated with fluorescence
microscopy is ideally suited for such studies but needs further
advances and capability to provide high-resolution information on
living cell membrane. On the other hand, AFM has been used to
image various ion channels in reconstituted, isolated purified mem-
brane, and in a fewoccasion in intact cellmembrane [11,26,40–42].
In a well-controlled study of purified amyloids [26], AFM
images show that a range of amyloids retained a globular structure
when imaged after their adsorption from solution and without any
membrane being present. In these studies, significantly, no to very
little amyloid fibers were observed (Fig. 5). The sizes of the
globular features generally ranged from 1 to 10 nm for different
amyloids. The size and volume of these amyloid structures were
consistent with their differing molecular weights — small
molecular weight amyloids had small diameter and overall volume
and large molecular weight amyloids had larger structural features.
Moreover, their size distribution was consistent with them being
mostly monomer and dimers [6,11,13,22,25,28,43,44].
The 3D structure of several amyloids after reconstitution in
membranes have been imaged using AFM [11,26,28,29,43,45]. A
variety of amyloids when reconstituted in lipid bilayer membrane
has been imaged and AFM images show the donut like features
(Fig. 9) formed from the globular amyloid structures in solution.
Upon closer examination at high resolution, ion channel like
structure with a central pore surrounded by a wall made of
oligomeric subunits can be observed for all of these amyloids
(Fig. 10). Subunit arrangements varied from rectangular with four
subunits, pentagonal with five subunits, hexagonal with six
subunits, to octahedralwith eight subunits.Octahedral arrangementwas only observed for serum amyloid A and alpha-synuclein,
pentamers were mainly observed for amylin, and for Abri
resolution was good enough for ultrastructural details only in a
few channels [26].
These results show that soluble amyloids, regardless of their
secondary structure (Fig. 1) can assume supramolecular 3D struc-
tures when reconstituted in bilayers. The stoichiometry (number of
subunits) of these channels were consistent with the overall
molecular weights measured for oligomers in the reconstituted
membrane (Fig. 6) and electrical recording [26]. On the other hand,
it will be difficult to compare the extracellular mass (volume) of
each amyloid channels with their molecular weight as the
theoretical models of their structures are just beginning to emerge.
Moreover, the stability of their channel-like conformations would
depend upon several factors, including pH, metal ions, cholesterol,
and gangliosides [46].
7. Overall ion channel hypothesis and structural evidence
Theoretical models for the structure of channels formed by
membrane bound Aβ are available (Fig. 11, Panel D) [47,48].
These models suggest that amyloid beta can insert partially at
differing angles and can form multimeric channels with a central
pore [47]. A recentmodel for alpha-synuclein–membrane complex
also indicates the possibility of fully or partially inserted peptide
chains (Fig. 11, Panel D)[49]. Such ion channel models were
designed as aggregates of identical subunits. For Aβ three types of
models were proposed with the pore forming region made up of β-
hairpin, the middle helixes, or the hydrophobic C-terminus helixes
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conformational change, and may explain why different conduc-
tance states are observed for single channels [32]. 3D structural
features observed inAFMstudies are consistentwith the theoretical
models derived for amyloid beta (Fig. 11, Panel D). The theoretical
model for alpha-synuclein channel derived from numerical
simulation and fitted with EM images [49] also conforms to the
3D channel structure derived from AFM imaging (Fig. 11, Panel
D). Molecular modeling and molecular dynamics simulations
showed that alpha-synuclein homodimers in a head-to-head
conformation can incorporate additional alpha-synuclein mole-
cules, leading to the formation of pentameric and hexameric ring
like structures (Fig. 11, Panel D) [49]. Whether the channel like
structure for other amyloids in AFM imaging can conform to
membrane-spanning respective channels is yet to be determined
and would have to wait till relevant theoretical models are
available. Moreover, the structural evidence for these channel
structures in neuronal plasma membrane is just beginning to beFig. 11. Structural evidence for amyloid ion channel paradigm and its relevance to AD pa
fluorescencemicroscopy and electrical recording supports the ion channelmodel. (A) Smal
incubation. (B)AFM image of globular/monomeric amyloids onmica surface. (C)AFM im
a larger scale bilayer patch. (D) Ion channel structure and activity. AFM images of individu
single channel currents recorded in parallel. Below the electrical recording graphs are show
insertion [47–49],with a top viewand a cross-sectional viewof transmembrane insertion. (E
existing ion channels ultimately leads to neuronal degeneration.examined. A recent abstract by S. Inoue supports such a possibility
(Inoue, S., unpublished data).
The 3D structural evidence for amyloid ion channels,
compatibility of these structures to known theoretical models and
their putative pathway for cell degeneration are summarized in
Fig. 11.Monomeric amyloid beta derived from its precursor (APP)
(Fig. 11, Panel A) are oligomeric (but mostly monomers and
dimers) in a physiologically relevant concentration and operating
environment (pH, temp, ionic balance) when imaged by AFM
(Fig. 11, Panel B). We provide structural evidence from atomic
force microscopy imaging that amyloid beta do not form fibers in
physiologically relevant condition at a physiological concentration
(Fig. 5). Interaction of many amyloids with lipid bilayer alters their
conformation to favor formation of small oligomeric complexes
(Fig. 6) and AFM imaging unequivocally show them forming ion
channel-like oligomeric structures with a central pore (Fig. 11,
Panel C and Panel D top row). In parallel, lipid bilayer ion channel
reconstitution electrophysiological studies show a typical channel-thophysiology. An array of studies using combination of AFM, biochemical analysis,
l oligomers ofAβ formedby enzymatic cleavage ofAPP remain globular up to 24hof
age of an array of ion channels randomly distributed in a lipid bilayer, the inset shows
al ion channels forAβ (left) andα-Synuclein (right) with a central pore aswell as their
n theoretical models of Aβ and α-Synuclein ion channels as well as their membrane
) Toxicity by calciumuptake anddisruption of ionic homeostasis throughAβ- or pre-
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(Fig. 11, panel D, second row from the top). Theoretical models
derived for amyloid channels and alpha-synuclein channels (in the
laboratories of Durrell and colleagues and Masliah and colleagues,
respectively) [47–49] support these ion channel structures. A
concern that these small peptides that could insert only partially in
the membrane does not seem to undermine the possibility of them
making an ion channel—model of amyloid membrane insertions
(Fig. 1, Panel D bottom row) support the channelmodel. In its early
though convincing phase of channel hypothesis, all amyloids
appear to have a common structural feature that is supported by
their channel-like electrical activity and permeability of cations.
Cell degeneration studies using non-fibrillar and globular amy-
loids from various laboratories support the role of these amyloid
channels in altering cell behavior. Panel D in Fig. 11 indicates
amyloid channel-induced alteration in cell behavior. Amyloid ion
channels would provide a direct pathway between the cell cyto-
plasm and the extracellular milieu and would mediate specific ion
transport [19,32,33]. Most significantly, cellular uptake of calcium
through these channels would destabilize the cell's calcium
homeostasis. For a small number of amyloid channels as could
occur during a transient and/or low concentration of globular
amyloids, the cytoplasmic calciumwould increasemarginally. This
will induce localized and subtle effects on synapses and synaptic
efficacy. On the other hand, for a sustained and/or high
concentration of globular amyloids that would allow formation
of a large number of amyloid channels, the cytoplasmic calcium
would increase significantly. In this scenario, there would be a
widespread neuronal/neuritic dysfunction and eventual degenera-
tion. An amyloid plaque will provide a constant source of local
release of globular amyloids resulting in localized and sustained
amyloid-induced pathophysiology. The details of this amyloid
channel model need to be understood, including the role of various
lipids, oxidative molecules, and other membrane-associated
complements in the channel formation as well as in their stability.
Nevertheless, amyloid channels provide a viable structural
substrate for testing tangible hypothesis underlying amyloid
diseases and designing effective therapeutics.
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